Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Myovant Sciences Ltd (NY: MYOV ) N/A UNCHANGED Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Myovant Sciences Ltd Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022 January 26, 2023 From Myovant Sciences, Inc. Via GlobeNewswire MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV January 25, 2023 From Kahn Swick & Foti, LLC Via Business Wire Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 November 16, 2022 From Myovant Sciences, Inc. Via GlobeNewswire Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources November 16, 2022 From Myovant Sciences, Inc. Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), October 31, 2022 From Brodsky & Smith LLC Via GlobeNewswire Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022 October 26, 2022 From Myovant Sciences, Inc. Via GlobeNewswire MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV October 25, 2022 From Kahn Swick & Foti, LLC Via Business Wire Myovant Sciences Cancels Second Quarter Earnings Conference Call October 24, 2022 From Myovant Sciences, Inc. Via GlobeNewswire MYOV STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Myovant Sciences Ltd. Is Fair to Shareholders October 24, 2022 From Halper Sadeh LLC Via Business Wire Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement October 23, 2022 From Myovant Sciences, Inc. Via GlobeNewswire Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08 October 18, 2022 From Myovant Sciences, Inc. Via GlobeNewswire CORRECTION -- Myovant Sciences, Inc. October 14, 2022 From Myovant Sciences, Inc. Via GlobeNewswire Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. October 14, 2022 From Myovant Sciences, Inc. Via GlobeNewswire Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares October 02, 2022 From Myovant Sciences, Inc. Via GlobeNewswire Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022 July 27, 2022 From Myovant Sciences, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.